StonvexLoading…
StonvexStonvexStonvexCore line items from STT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.94B | $13.00B | $11.95B | $12.15B |
Operating Income | $3.73B | $3.40B | $2.32B | $3.33B |
Net Income | $2.94B | $2.69B | $1.94B | $2.77B |
EPS (Diluted) | $9.40 | $8.21 | $5.58 | $7.19 |
Total Assets | $366.05B | $353.24B | $297.26B | $301.45B |
Total Liabilities | $338.21B | $327.91B | $273.46B | $276.26B |
Cash & Equivalents | $4.43B | $3.15B | $4.05B | $3.97B |
Free Cash Flow OCF − CapEx | $10.84B | $-14.14B | $-126.00M | $11.22B |
Shares Outstanding | 279.08M | 288.77M | 301.94M | 349.02M |